Venture Capital Investors

Cure Ventures

Cure Ventures is a VC investing group that helps tech entrepreneurs.

Venture Investor Overview

Venture Investor
Cure Ventures
Status
Active
Investor Type
Venture Capital
Activity Level
1 transaction
Funds Raised
Unknown
Industry Focus
Biopharmaceutical

Contact Information

Contact
David Fallace
Title
Managing Partner
Mailing Address
349 Newbury Street, 2nd Floor
Boston, MA 02115
USA
Phone
Undisclosed
Website
www.curevc.com
Email Address
[email protected]

Background Information

Overview
Cure Ventures is a life sciences venture capital firm focusing on investing in de novo company formation around groundbreaking curative technologies. Above all else, the Cure team leads with respect for people and for science. Led by highly accomplished industry veterans, Cure's investment strategy is founded on three tenets: A seed funding model that allows Cure to de-risk the science and set companies up for success; genetic validation that increases the probability of success; and embedded Cure operators to drive the best day-to-day decision making in collaboration with founders.
Profile
Cure Ventures LinkedIn Company Profile
Social Media
Cure Ventures Company Twitter Account
Company News
Cure Ventures News
Facebook
Cure Ventures on Facebook
YouTube
Cure Ventures on YouTube
Last Transaction
4/21/2026

Transaction History

Our records indicate that Cure Ventures invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Tortugas Neuroscience
4/21/2026
$106,000,000

 

Investor Contacts

Title
Name
Email & Social
Partner
William Amsbaugh
  William Amsbaugh LinkedIn Profile  William Amsbaugh Twitter Account  William Amsbaugh News  William Amsbaugh on Facebook
Managing Partner
David Fallace
  David Fallace LinkedIn Profile  David Fallace Twitter Account  David Fallace News  David Fallace on Facebook
Partner
Jeno Gyuris
  Jeno Gyuris LinkedIn Profile  Jeno Gyuris Twitter Account  Jeno Gyuris News  Jeno Gyuris on Facebook
Partner
May Han
  May Han LinkedIn Profile  May Han Twitter Account  May Han News  May Han on Facebook
Partner
Jeffrey Jonas
  Jeffrey Jonas LinkedIn Profile  Jeffrey Jonas Twitter Account  Jeffrey Jonas News  Jeffrey Jonas on Facebook
Partner
Drew King
  Drew King LinkedIn Profile  Drew King Twitter Account  Drew King News  Drew King on Facebook
Managing Partner
Richard Lim
  Richard Lim LinkedIn Profile  Richard Lim Twitter Account  Richard Lim News  Richard Lim on Facebook
Partner
Kenzie Maclsaac
  Kenzie Maclsaac LinkedIn Profile  Kenzie Maclsaac Twitter Account  Kenzie Maclsaac News  Kenzie Maclsaac on Facebook
Partner
Annie Mitsak
  Annie Mitsak LinkedIn Profile  Annie Mitsak Twitter Account  Annie Mitsak News  Annie Mitsak on Facebook
Partner
Albert Robichaud
  Albert Robichaud LinkedIn Profile  Albert Robichaud Twitter Account  Albert Robichaud News  Albert Robichaud on Facebook
Managing Partner
Lou Tartaglia
  Lou Tartaglia LinkedIn Profile  Lou Tartaglia Twitter Account  Lou Tartaglia News  Lou Tartaglia on Facebook

 

Funds

No fund closings have been recorded for this company.

 

Portfolio Companies

Cure Ventures has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Tortugas Neuroscience

 

 

 

 

Browse more venture capital investors:

Cure Kids Ventures | Curewell Capital

 

Share this article

 

About Our VC & M&A Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2026. Gaebler Ventures. All rights reserved.